Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4252/wjsc.v13.i2.139 http://scihub22266oqcxt.onion/10.4252/wjsc.v13.i2.139 33708343!7933990!33708343     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Stem+Cells 2021 ; 13 (2): 139-154 Nephropedia Template TP {{tp|p=33708343|t=2021. Targeting mesenchymal stem cell therapy for severe pneumonia patients |pdf=|usr=}}{{33708343}} gab.com Text Targeting mesenchymal stem cell therapy for severe pneumonia patients JO: World J Stem Cells http://www.kidney.de/pget.php?&tw=1&pmid=33708343 #FOAvip Pneumonia is the inflammation of the lungs and it is the world's leading cause of death for children under 5 years of age. The latest coronavirus disease 2019 (COVID-19) virus is a prominent culprit to severe pneumonia. With the pandemic running rampant for the past year, more than 1590000 deaths has occurred worldwide up to December 2020 and are substantially attributable to severe pneumonia and induced cytokine storm. Effective therapeutic approaches in addition to the vaccines and drugs under development are hence greatly sought after. Therapies harnessing stem cells and their derivatives have been established by basic research for their versatile capacity to specifically inhibit inflammation due to pneumonia and prevent alveolar/pulmonary fibrosis while enhancing antibacterial/antiviral immunity, thus significantly alleviating the severe clinical conditions of pneumonia. In recent clinical trials, mesenchymal stem cells have shown effectiveness in reducing COVID-19-associated pneumonia morbidity and mortality; positioning these cells as worthy candidates for combating one of the greatest challenges of our time and shedding light on their prospects as a next-generation therapy to counter future challenges. Twit Text FOAVip Targeting mesenchymal stem cell therapy for severe pneumonia patients ????World J Stem Cells http://www.kidney.de/pget.php?&tw=1&pmid=33708343 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33708343 #FOAvip English Wikipedia <ref>{{Cite pmid|33708343}}</ref> Targeting mesenchymal stem cell therapy for severe pneumonia patients #MMPMID33708343 Lam G; Zhou Y; Wang JX; Tsui YP World J Stem Cells 2021[Feb]; 13 (2): 139-154 PMID33708343show ga Pneumonia is the inflammation of the lungs and it is the world's leading cause of death for children under 5 years of age. The latest coronavirus disease 2019 (COVID-19) virus is a prominent culprit to severe pneumonia. With the pandemic running rampant for the past year, more than 1590000 deaths has occurred worldwide up to December 2020 and are substantially attributable to severe pneumonia and induced cytokine storm. Effective therapeutic approaches in addition to the vaccines and drugs under development are hence greatly sought after. Therapies harnessing stem cells and their derivatives have been established by basic research for their versatile capacity to specifically inhibit inflammation due to pneumonia and prevent alveolar/pulmonary fibrosis while enhancing antibacterial/antiviral immunity, thus significantly alleviating the severe clinical conditions of pneumonia. In recent clinical trials, mesenchymal stem cells have shown effectiveness in reducing COVID-19-associated pneumonia morbidity and mortality; positioning these cells as worthy candidates for combating one of the greatest challenges of our time and shedding light on their prospects as a next-generation therapy to counter future challenges. äTargeting mesenchymal stem cell therapy for severe pneumonia patients (epmc).pdf DeepDyve Pubget Overpricing